Showing 1161-1170 of 1717 results for "".
- Taking Control: Beyond Medications for Tension Headaches in Adolescentshttps://practicalneurology.com/diseases-diagnoses/headache-pain/pn0908-teen-tension-pdf/30999/Managing Chronic Daily Headaches in Adolescents: Challenges and Behavioral InterventionsChronic daily headaches (CDH) are increasingly prevalent among adolescents, a demographic grappling with rising rates of anxiety, depression, and various stressors. Tension-type headaches, in particular, are on t
- When should you send headache patients for neuroimaging studies?https://practicalneurology.com/diseases-diagnoses/headache-pain/PN0608Neuroimaging-pdf/31016/In the evolving landscape of neurology, the diagnosis of migraines remains predominantly clinical, a practice rooted in ancient medical history. Despite advancements in neuroimaging technologies, clinical evaluation based on criteria from the International Headache Society remains central. Historica
- Pain Managementhttps://practicalneurology.com/diseases-diagnoses/headache-pain/PN0608PainMgmnt-pdf/31018/Tailoring Chronic Pain Treatment to the PatientChronic pain remains a prevalent issue in the United States, affecting approximately 50 million individuals and imposing an economic burden of $85-90 billion annually. Defined as pain persisting beyond three months, chronic pain is considered maladaptiv
- Pain Managementhttps://practicalneurology.com/diseases-diagnoses/headache-pain/pn0308-pain-mngmnt-pdf/31046/Exploring Central Nervous System Mechanisms in Chronic PainChronic pain remains a significant challenge in neurology, intricately involving both the peripheral nervous system (PNS) and the central nervous system (CNS). Dr. Charles Argoff’s comprehensive analysis delves into the pathophysiology of ch
- Epilepsy Essentialshttps://practicalneurology.com/diseases-diagnoses/epilepsy-seizures/PN1107epilepsy-pdf/31101/Febrile seizures are a prevalent neurological concern in pediatric populations, affecting approximately 4% of children in the United States. Typically occurring between one month and five years of age, with a peak incidence at 18 to 22 months, these seizures are triggered by febrile illnesses rather
- Pain Managementhttps://practicalneurology.com/diseases-diagnoses/headache-pain/pn0907-painmngmt-pdf/31125/Interconnections Between Neuropathic Pain, Depression, Anxiety, and Quality of LifeChronic neuropathic pain significantly impacts patients' quality of life, often intertwining with psychiatric comorbidities such as depression and anxiety. In his insightful article, Dr. Charles Argoff explores how th
- Business Advisorhttps://practicalneurology.com/columns/practice-management/business-advisor/31120/In the September 2007 issue of *Practical Neurology*, Mary McDermott addresses a critical concern for neurologists: how to secure appropriate compensation for the increasing time spent with patients, particularly within an aging and chronically ill population. The article highlights the potential of
- Keeping Stroke Patients Safe and Securehttps://practicalneurology.com/diseases-diagnoses/stroke/pn0807-stroke-fea-pdf/31139/Surviving an ischemic stroke brings immediate relief for patients, yet it introduces lifelong vulnerabilities, notably the risk of recurrent and potentially more severe strokes. Effective supportive care for stroke survivors centers on two primary objectives: minimizing injury to ischemic brain tiss
- Dementia Insightshttps://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/pn0807-dementia-pdf/31134/Recent advancements in Alzheimer’s disease (AD) research are prompting a reevaluation of the traditional amyloid-beta (Aβ) hypothesis. Historically, the focus has been on Aβ42 as the primary pathogenic species driving AD, with Aβ40 considered less harmful. However, emerging studies suggest a more nu
- Expert Opinionhttps://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/PN0507ExpertOp-pdf/31176/Atypical Antipsychotics in Alzheimer’s Disease: Balancing Efficacy and SafetyIn a case report by Dr. Richard M. Sobel, a 79-year-old patient with Alzheimer’s disease (AD) exhibits progressive cognitive decline accompanied by memory loss, confusion, delusions of theft, and occasional combativeness. D